Почетна › Кронова болест › Kolorado
Kliničke studije za Кронова болест u državi Kolorado
18 studija za Кронова болест traži učesnike na lokacijama u državi Kolorado.
Gradovi u državi Kolorado
Zvanični tekst studije (na engleskom)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 5026), Aurora
- Peak Gastroenterology Associates ( Site 5023), Colorado Springs
- South Denver Gastroenterology, PC ( Site 5132), Englewood
- и још 1
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- South Denver Gastroenterology, Englewood
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483073A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates - Colorado Springs, Colorado Springs
Тражи се учесникФаза 2
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06226883A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- South Denver Gastroenterology, Englewood
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483099A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07196722A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577843A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07499232A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400032, Colorado Springs
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Peak Gastroenterology Associates, Colorado Springs
- Rocky Mountain Endocopy Centers LLC, Littleton
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado Springs
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184944An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- UCHealth Digestive Health Center - Anschutz Medical Campus-Site Number: 8400085, Aurora
- Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado Springs
- Gastroenterology of the Rockies - Denver-Site Number: 8400122, Denver
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Children's Hospital Colorado - Aurora /ID# 255764, Aurora
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 20. 10. 2026. · NCT05995353Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 265557, Colorado Springs
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Colorado, Aurora
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT05230173A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 27. 5. 2026. · NCT06227910Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 4. 2026. · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Colorado Springs
- Mirador Therapeutics Selected Site, Littleton
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.